Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Código QR

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Here, the authors compare the crystal structures and investigate the neutralization mechanisms of three neutralizing antibodies against SARS-CoV-2 and find that one antibody, P2C-1F11, closely mimics binding of receptor ACE2 and displays the most potent neutralizing activity in vitro, as well as con...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiwan Ge, Ruoke Wang, Bin Ju, Qi Zhang, Jing Sun, Peng Chen, Senyan Zhang, Yuling Tian, Sisi Shan, Lin Cheng, Bing Zhou, Shuo Song, Juanjuan Zhao, Haiyan Wang, Xuanling Shi, Qiang Ding, Lei Liu, Jincun Zhao, Zheng Zhang, Xinquan Wang, Linqi Zhang
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/838f1d2ad0e443bda1e93e6840e828b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
por: Qi Zhang, et al.
Publicado: (2021)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
por: Yanyun Du, et al.
Publicado: (2021)

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
por: Haixia Zhou, et al.
Publicado: (2019)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Changhai Lei, et al.
Publicado: (2020)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Lin Cheng, et al.
Publicado: (2021)

HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
por: Junying Sun, et al.
Publicado: (2017)

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
por: Shuyuan Zhang, et al.
Publicado: (2021)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zengyuan Zhang, et al.
Publicado: (2021)

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
por: Qian-Ying Zhu, et al.
Publicado: (2021)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Shiho Tanaka, et al.
Publicado: (2021)

Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
por: Georgina I. López-Cortés, et al.
Publicado: (2021)

A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
por: Ami Miller, et al.
Publicado: (2021)

A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
por: Zhenlin Yang, et al.
Publicado: (2021)

Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption.
por: Wenlin Ren, et al.
Publicado: (2021)

Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
por: Wenlin Ren, et al.
Publicado: (2021)

High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
por: Chao Liu, et al.
Publicado: (2021)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Ivan T. Lee, et al.
Publicado: (2020)

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
por: Yannick Galipeau, et al.
Publicado: (2021)

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
por: Xing Zhu, et al.
Publicado: (2021)

Blocking facial mimicry during binocular rivalry modulates visual awareness of faces with a neutral expression
por: Thomas Quettier, et al.
Publicado: (2021)

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
por: Federico Bertoglio, et al.
Publicado: (2021)

Tracing the origin and evolution of supergene mimicry in butterflies
por: Wei Zhang, et al.
Publicado: (2017)

Study on the Clinical Significance of ACE2 and Its Age-Related Expression
por: Gu J, et al.
Publicado: (2021)

Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
por: Hui Wang, et al.
Publicado: (2014)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Jinsung Yang, et al.
Publicado: (2020)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Ronit Rosenfeld, et al.
Publicado: (2021)

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
por: Shuang Wang, et al.
Publicado: (2020)

A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels
por: Juliano Alves, et al.
Publicado: (2021)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
por: Tingting Li, et al.
Publicado: (2021)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Tong Xiang, et al.
Publicado: (2018)

The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor
por: Chuncui Huang, et al.
Publicado: (2021)

Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Jinsung Yang, et al.
Publicado: (2021)

Revealing the intrinsic superconducting gap anisotropy in surface-neutralized BaFe2(As0.7P0.3)2
por: Ziming Xin, et al.
Publicado: (2021)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Yanqiu Gong, et al.
Publicado: (2021)

PDZ-Containing Proteins Targeted by the ACE2 Receptor
por: Célia Caillet-Saguy, et al.
Publicado: (2021)

Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans
por: Xia Xue, et al.
Publicado: (2021)

Western Mimicry or Cultural Hybridity
por: Nergis Mazid
Publicado: (2002)

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers
por: He C, et al.
Publicado: (2021)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Christopher J. Day, et al.
Publicado: (2021)

The possible role of molecular mimicry in SARS-CoV-2-mediated autoimmunity: an immunobiochemical basis
por: Dženan Kovačić, et al.
Publicado: (2021)